2012, Number s1
<< Back Next >>
Rev Cub Oftal 2012; 25 (s1)
General considerations about hyphema secondary to ocular trauma and closed globe injure
Fernández AL, Martínez UJG, Rodríguez GDT, Piloto DI, Díaz ÁY, Álvarez CGA
Language: Spanish
References: 35
Page:
PDF size: 109.19 Kb.
ABSTRACT
Hyphema, common consequence of the ocular trauma, is considered a diagnostic and therapeutic emergency due to the ocular lesions that determine their appearance and the complications that may occur. However, the treatment of hyphema continues being a challenge since unanimous consent does not exist yet. This study intended to delve into questions that are controversial as the hospitalization, the use of midriatic drops use, ocular patches, systemic steroids, aminocaproic acid inhibitors, the early surgery, among others.
REFERENCES
Colectivo de autores. Diccionario terminológico de ciencias médicas. 10ma. Ed. España: Salvat editores; 1972.
Sheppard JD Jr. Hyphema. E medicine; 2012. Disponible en: http://emedicine.medscape.com/article/1190165-overview
Labrada YH, Flores A, González L. Traumatología ocular en niños. Rev Cubana Oftalmol. 2003 [citado 20 de agosto de 2012];16(2). Disponible en: http://bvs.sld.cu/revistas/oft/vol16_2_03/oft04203.htm
Miqueli M, Ortiz E. Traumas oculares y glaucoma. Rev Cubana Oftalmol. 2003 [citado 20 de agosto de 2012];16(2). Disponible en: http://bvs.sld.cu/revistas/oft/vol16_2_03/oft03203.htm
Irak-Dersu I. Glaucoma, Hyphema: Treatment & Medication. E medicine; 2012. Disponible en: http://emedicine.medscape.com/article/1206635-treatment
Lai JC, Fekrat S, Barrón Y, Goldberg MF. Traumatic hyphema in children. Risk factors for complications. Arch Ophthalmol. 2001;119(1):64-70.
Jara E, Colom G, Santiesteban R. Traumatismos oculares. En: Colectivo de autores. Pediatría Tomo III. La Habana: Editorial Ciencias Médicas; 2007. p. 1344-51.
González IX, Villavicencio A, Campos LE. Escala pronóstica para agudeza visual en hipema traumático. Rev Mex Oftalmol. 2007;81(6):301-6.
Papaconstantinou D, Georgalas I, Kourtis N, Karmiris E, Koutsandrea C. Contemporary aspects in the prognosis of traumatic hyphemas. Clin Ophthalmol. 2009;3:287-90.
Wolffsohn JS, Davies LN. Advances in anterior segment imaging. Curr Opin Ophthalmol. 2007;18(1):32-8.
Karaman K, Culie S, Erceg I. Treatment of post-traumatic trabecular Mashwork thrombosis and secondary glaucoma with intracameral tissue plasminogen activator in previously unrecognized sickle cell anemia. Coll. Antropol. 2005;29(1):123-6.
Walton W, Von Hagen S, Grigorian R, Zarbin M. Management of traumatic hyphema. Surv Ophthalmol. 2002;47(4):297-334.
Rocha KM, Nogueira E, Melo LA Jr, Simeren N. Outpatient management of traumatic hyphema in children: Prospective evaluation. J AAPOS. 2004;8(4):357-61.
Thangaraj MA. Treatment of traumatic hyphema. West Indian Med. 1995;44(2):43-4.
Beiran I, Talmon T, Miller B. Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid. Isr Med Assoc J. 2002;4(11):1009-10.
Sihota R, Kumar S, Gupta V, Dada T, Kashyap S, Insan R, et al. Early predictors of traumatic glaucoma after closed globe injury: trabecular pigmentation, widened angle recess, and higher baseline intraocular pressure. Arch Ophthalmol. 2008;126(7):921-6.
Grove N. Optic atrophy secondary to sickle cell hyphema is avoidable. Ophthalmology Times. 2008;33(17):1-66.
Luksza L, Homziuk M, Nowakowska-Klimek M, Glasner L, Iwaszkiewicz-Bilikiewicz B. Traumatic hyphema caused by eye injuries. Klin Oczna. 2005;107(4-6):250-4.
Romano PE, Phillips PJ. Traumatic hyphema: a critical review of the scientifically catastrophic history of steroid treatment therefore; and a report of 24 additional cases with no rebleeding after treatment with the Yasuna systemic steroid, no touch PLUS protocol. Binocul Vis Strabismus Q. 2000;15(2):187-96.
Uusilato R, Ranta L. Management of traumatic hyphema in children. An analysis of 340 cases. Arch Ophthalmol. 1988;106(9):1207-9.
Vaughan DG, Asbury T. Vaughan & Asbury's General Ophthalmology. 17th. Ed. USA:Mcgraw-Hill; 2008.
Crouch ER Jr. Traumatic hyphema. J Pediatr Ophthalmol Strabismus. 1986;23(2):95-7.
Rahmani B, Jahadi HR. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial. Ophthalmology. 1999;6(2):375-9.
Crouch E, Norfolk VA. Systemic Steroids: An alternative to systemic aminocaproic acid to prevent rebleeding in traumatic hyphema-reply. Arch Ophthalmol. 1987;105(5):611.
Fourman S, Kutner B. Comments on continued clinical research on systemic aminocaproic acid for traumatic hyphema-reply. Arch Ophthalmol. 1987;105(5):612.
Romano PE. Systemic Steroids: An alternative to systemic aminocaproic acid to prevent rebleeding in traumatic hyphema. Arch Ophthalmol. 1987;105(5):610.
Romano PE. Comments on continued clinical research on systemic aminocaproic acid for traumatic hyphema. Arch Ophthalmol. 1987;105(5):611-2.
Pieramici DJ, Goldberg MF, Melia M, Fekrat S. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema. Ophthalmology. 2003;110(11):2106-12.
Karkhaneh R, Naeen M, Chams H. Topical amiriocaproic acid to prevent rebleeding in cases of traumatic hyphema. Eur J Ophthalmol. 2003;13(11):57-61.
Williams DF, Han DP. Rebleeding in experimental traumatic hyphema treated with intraocular tissue plasminogen activator. Arch Ophthalmol. 1990;108(2):264-6.
Lambrou FH, Snyder RW, Williams GA. Use of tissue plasminogen activator in experimental hyphema. Arch Ophthalmol. 1987;105(7):995-7.
Yu T, Dahan E, Yin ZQ, Levitz LM. Use of an anterior chamber maintainer in the surgical management of traumatic hyphaemas. Clin Experiment Ophthalmol. 2008;36(3):206-8.
Tapia JL. Infarto esplénico por anemia falciforme relacionado con la altura. Rev Venez Cir. 2006;59(2):60-5.
Recchia FM, Saluja RK, Hammel K, Jeffers JB. Outpatient management of traumatic microhyphema. Ophthalmology. 2002;109(8):1465-70.
Kelly JL, Blomquist PH. Management of traumatic hyphema in Texas. Tex Med. 2002;98(4):56-61.